Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,616 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06974370RecruitingPhase 2
Avoiding brain radiation when chemo or other drugs work
This trial tests whether some people with brain metastases from solid tumors can safely skip radiation if their cancer drugs (like targeted therapy, immunotherapy, or certain chemotherapies) shrink the brain tumors. You will get MRI scans to see if the drugs are working.
Burlington, VermontAges 18 years+ - NCT06976944RecruitingPhase 2
Pembrolizumab, Paclitaxel, and Bevacizumab for Triple-Negative Breast Cancer
This trial tests a combination of the immunotherapy drug pembrolizumab, the chemotherapy paclitaxel, and possibly the targeted drug bevacizumab for people with triple-negative breast cancer that has returned after treatment. It aims to see if adding bevacizumab improves outcomes for patients whose tumors are PD-L1 positive.
Nagoya, Aichi-kenAges 18 years+ - NCT06977698Recruiting
Detecting cancer margins during breast surgery
This study tests a new method to check for leftover cancer cells and lymph node spread during breast surgery. It may help doctors make sure all cancer is removed the first time.
NottinghamAges Any age - NCT06981208Recruiting
ChatGPT and surgeon teamwork for breast reconstruction talks
This trial tests whether using a ChatGPT tool alongside your surgeon can make your breast reconstruction consultation clearer and more satisfying. It may help you feel more informed and engaged in decisions about your care.
St Louis, MissouriAges 18 years+ - NCT06870630Recruiting
Comparing two myotomy methods for type 2 achalasia
This trial tests two muscle-cutting procedures for people newly diagnosed with type 2 achalasia (a swallowing disorder). The goal is to see if a more complex myotomy works better than the standard one.
Hyderabad, TelanganaAges 18–75 - NCT06966700RecruitingPhase 3
Study of Sac-TMT in Early High-Risk Breast Cancer
This study tests a new drug called Sacituzumab Tirumotecan (Sac-TMT) for people with early-stage, high-risk breast cancer that hasn't spread. The drug is given before surgery to see if it can shrink tumors and improve outcomes.
Gilbert, ArizonaAges 18 years+ - NCT06970275Recruiting
PET-CT imaging study for cancer surgery patients
This trial uses a special PET-CT scanner to take high-resolution images of cancer tumors that have been surgically removed. The goal is to see how well these images match the results from standard lab tests, such as pathology, and to track long-term outcomes.
AalstAges 18 years+ - NCT06972355Recruiting
Treadmill walking with hidden vision for stroke rehab
This trial tests if walking on a treadmill with a screen that hides vision can help people recovering from a stroke improve their balance and mobility. It is for people who had a stroke less than 6 months ago and can already walk a little with support.
MetzAges 18 years+ - NCT06963723Recruiting
Screening for financial hardship in advanced cancer
This study screens people with advanced cancer for financial problems. It aims to see if catching these problems early can improve your care and well-being.
Phoenix, ArizonaAges 21 years+ - NCT06962579Recruiting
Exercise to prevent chemotherapy nerve damage
This study tests whether a personalized exercise program at home can help prevent nerve damage (peripheral neuropathy) caused by certain chemotherapy drugs. It is for people with breast, gynecological, or colon cancer starting a new chemotherapy treatment.
EdegemAges 18 years+ - NCT06966388RecruitingPhase 1
Azelaic acid cream for breast cancer patients during radiation
This study tests whether using a topical azelaic acid cream twice daily during radiation therapy is feasible for breast cancer patients. The cream may help reduce skin side effects from radiation, and the study focuses on people with certain skin types that tan easily or have more pigment.
Richmond, VirginiaAges 18 years+ - NCT06964802Recruiting
Cold salt water foot bath to prevent nerve damage from chemo
This trial tests whether soaking your feet in cold salt water before chemotherapy can help prevent nerve damage (called peripheral neuropathy) that is a common side effect of the breast cancer drug paclitaxel.
Istanbul, UskudarAges 18 years+ - NCT06967961Recruiting
Looking for cancer cells that carry two markers in the blood
This trial is studying a special type of cell that shows up in the blood of people with certain advanced cancers. It aims to find out if these cells can help doctors better understand the cancer and guide treatment.
ToulouseAges 18 years+ - NCT06965998RecruitingPhase 2/Phase 3
Comparing two doses of rivaroxaban for leg vein clots
This trial tests if a full dose of rivaroxaban (a blood thinner) works better than a lower preventive dose for treating a superficial vein clot in the leg. It aims to find the safest and most effective way to stop the clot from getting worse or causing a more serious clot.
Ottawa, OntarioAges 18 years+ - NCT06547515Recruiting
Bone and muscle health after sleeve gastrectomy
This study looks at how sleeve gastrectomy surgery affects bone and muscle health in men and women at different life stages (before and after menopause). It compares people having the surgery with those who qualify but don't have it.
QuébecAges 18 years+ - NCT06883149RecruitingPhase 1
Combination treatment for solid tumors that stopped responding to prior therapy
This trial tests a new combination of two drugs (PIN plus an anti-PD1 immunotherapy) for people with advanced solid tumors that either did not respond to standard treatment or have tumor types known to have low response to immunotherapy, like liver cancer. The goal is to see if this combination can help shrink or control the cancer.
Beijing, Beijing MunicipalityAges 18–75 - NCT06924398RecruitingPhase 2
Post-surgery targeted therapy for remaining lung nodules in EGFR-mutant NSCLC
This trial tests whether a targeted therapy pill (EGFR-TKI) can control small spots in the other lung after surgery for early-stage lung cancer. It's for people whose cancer has a specific EGFR gene change and who still have suspicious spots in the opposite lung after one side is removed.
Guangzhou, GuangdongAges 18–75 - NCT06928350Recruiting
Normal esophagus readings in healthy Indian adults
This trial is studying normal acid and fluid movement in the esophagus of healthy people in India. It will help doctors better understand what is typical, which may improve care for people with acid reflux or other swallowing issues.
Hyderabad, TelanganaAges 18–50 - NCT06292286Recruiting
Second surgery for recurrent ovarian cancer that responds to platinum
This trial tests whether having a second surgery after initial treatment can help people with ovarian cancer that came back but still responds to platinum-based chemotherapy. It may offer another option to remove remaining tumors and delay further treatments.
Hong KongAges 18 years+ - NCT06953089RecruitingPhase 2
Combination therapy study for advanced solid tumors
This trial is testing two new drugs (DB-1311 with BNT327 or DB-1305) in people with certain advanced or metastatic solid tumors that have not responded to prior treatments. It aims to see if the combination shrinks tumors or slows cancer growth.
Los Angeles, CaliforniaAges 18 years+ - NCT06961747RecruitingPhase 1
Zilucoplan levels in breast milk of healthy nursing mothers
This study measures how much of the drug zilucoplan passes into breast milk. Healthy nursing mothers who are already planning to stop breastfeeding can take part to help understand how the drug is processed.
San Antonio, TexasAges 18 years+ - NCT06961565RecruitingPhase 1
Study of PAS-004 for adults with NF1 and plexiform neurofibromas
This trial tests an oral medication called PAS-004 for adults with Neurofibromatosis Type 1 who have at least one symptomatic plexiform neurofibroma that cannot be surgically removed. The goal is to see if the drug can shrink these tumors or improve symptoms, and to understand side effects.
Birmingham, AlabamaAges 18 years+ - NCT06281223Recruiting
Brain and spinal cord connection study in spasticity
This study looks at how the brain and spinal cord connect in children with spasticity (muscle stiffness). It will help doctors understand more about this condition by studying patients who are already scheduled for surgery to reduce stiffness.
NiceAges 3–17 - NCT06960720Recruiting
Weight lifting program for breast cancer fatigue
This trial tests whether a 3-month resistance exercise program (like lifting weights) can help reduce fatigue in women who have had breast cancer. You may be eligible if you were diagnosed with non-metastatic breast cancer 1-3 years ago and feel tired, even if only a little.
Morgantown, West VirginiaAges 18 years+
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,616 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.